# CellFX® nsPFA™ Cardiac Surgery System to Treat Atrial Fibrillation

> **NCT06355063** · NA · RECRUITING · sponsor: **Pulse Biosciences, Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Atrial Fibrillation
- Surgery
- Ablation of Atrial Fibrillation
- Clamp Study

## Interventions

- **DEVICE:** CellFX® nsPFA™ Cardiac Surgery System

## Key facts

- **NCT ID:** NCT06355063
- **Lead sponsor:** Pulse Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-31
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06355063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06355063, "CellFX® nsPFA™ Cardiac Surgery System to Treat Atrial Fibrillation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06355063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*